Cardio-protective Effect of Metformin in Patients Undergoing PCI

Summary

This is a two-arm randomized parallel study. Patients who will be meeting the above-mentioned criteria and agree to take part in the study, were asked to sign an informed consent prior conducting the study. The whole study protocol were presented to the local institutional review board (IRB).

Timeline

Start

2019-12-09

Primary completion

2021-12-09

Completion

2024-12

Drugs

Indications